Jafron Biomedical | Sustainability Performance
Developer and manufacturer of blood purification devices and related biomedical products.
1989
China
1,001 - 5,000 employees
Medical Device
$100M - 500M in revenue
$100M - 500M in profitability
Sustainability Ranking & Industry Benchmark
#9485
Overall#441
in China#139
in Medical DeviceSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and exclusionsB-corp & CDPFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$282.1MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
9.8%FY2025
R&D as % of revenue
R&D as % of revenue
Industry benchmark
Powered by illuminem
Return on invested capital
11.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.3
▼ 7.0%
0.4
▼ 8.0%
0.3
▼ 6.7%
2.5
2028Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Available
Human rights policy
Available
Recycling policy
Available
Workplace health & safety policy
Available
25%
Independent Directors
3 out of 12 incl. management
Overall score
68
Environment
52
Social
82
Governance
70
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
CDP Scores
Climate Score
Not disclosed
Water Score
Not disclosed
A
A-
B
B-
C
C-
D
D-
